Table 2

Levels of vit-2, vit-5 and sod-3 mRNA in sterile strains

Genotype

Day

vit-2 #

vit-5 #

sod-3 #


fem-1(hc17)

1

0.33 (0.12, 7)*

0.041 (0.09, 7)*

0.93 (0.1, 6)


fem-1(hc17)

2

0.15 (0.08, 4)*

0.34 (0.18, 4)*

3.0 (3.7, 2)


fem-1(hc17)

4

0.092 (0.03, 3)

0.20 (0.09, 3)

1.2 (1.4, 2)


fem-1(hc17)

6

0.094 (0.03, 7)

0.13 (0.08, 7)

0.63 (0.5, 6)


fem-3(q20)

1

1.1 (0.76, 4)

1.3 (1.1, 4)

0.98 (1.2, 4)


fem-3(q20)

2

1.1 (0.60, 4)

1.1 (0.54, 4)

4.4 (6.8, 4)


fem-3(q20)

4

0.53 (0.22, 4)

0.43 (0.18, 4)

1.69 (1.2, 4)


fem-3(q20)

6

0.16 (0.12, 3)

0.05 (0.04, 3)*

2.72 (2.31, 3)


fem-1(hc17) × wildtype males

1

0.75 (0.22, 4)^

0.71 (0.23, 4)

0.53 (0.10, 4)


fem-1(hc17) × wildtype males

2

0.38 (0.14, 2)

0.55 (0.17, 2)

0.12 (0.15, 2)


fem-1(hc17) × wildtype males

4

0.082 (1 trial)

0.16 (1 trial)

0.24 (1 trial)


fem-1(hc17) × wildtype males

6

0.357 (0.37, 3)

0.41 (0.4, 3)

0.20 (0.12, 3)


# Average mRNA level (SD, trials)

* p < 0.05 vs. wildtype, same day, T-test.

^ p < 0.05, vs. fem-1(hc17) unmated, T-test.

DePina et al. BMC Physiology 2011 11:11   doi:10.1186/1472-6793-11-11

Open Data